摘要【目的】综合评估视黄醇结合蛋白(RBP)水平与非酒精性脂肪肝(NAFLD)的关系。【方法】计算机检索PubMed、Web of Science、Cochrane图书馆、中国知网、中国生物医学文献数据库、维普期刊资源整合服务平台和万方数据知识服务平台,收集有关血清RBP水平与NAFLD关系的病例对照研究,检索时限为从各数据库建库至2017年12月。由2名研究人员独立提取资料并评价纳入文献的质量,采用RevMan 5.3软件进行Meta分析。【结果】共纳入14篇文献,NAFLD患者(观察组)血清RBP水平高于非NAFLD患者,即对照组患者(SMD=0.96,95%CI:0.63~1.28,P<0.05)。亚组分析显示,合并2型糖尿病的患者中观察组的RBP水平高于对照组(SMD=0.70,95%CI:0.42~0.97,P<0.001);≥18岁患者RBP水平高于对照组(SMD=0.82,95%CI:0.55~1.09,P<0.001),而年龄<18岁患者的RBP水平与对照组差异无统计学意义(SMD=1.68,95%CI:-0.22~3.59,P=0.08)。敏感性分析与发表偏倚分析表明研究结果稳定、无明显发表偏倚。【结论】18岁以上成人NAFLD患者血清RBP水平高于非NAFLD者。
Abstract：【Objective】To evaluate the association between retinol binding protein (RBP) and non-alcoholic fatty liver disease (NAFLD).【Methods】A document retrieval was conducted by retrieval systems,including PubMed,Web of Science,Cochrane Library,Chinese National Knowledge Infrastructure(CNKI), CBM, VIP and Wan Fang Database, to collect the published papers of case-control studies on the theme of association between serum RBP and NAFLD up to Dec. 2017.Data collection and quality assessment were performed by two authors, respectively.All the meta-analysis were conducted with software RevMan 5.3.【Results】A total of 14 qualified studies were included in the meta-analysis.The analysis showed that serum RBP might be significantly higher in patients with NAFLD than non-NAFLD patients (SMD=0.96,95%CI:0.63~1.28,P<0.05)。Clinical subtype specific subgroup analysis showed that RBP might be higher in patients with type 2 diabetes mellitus and NAFLD than non-NAFLD patients (SMD=0.70,95%CI:0.42~0.97,P<0.001).Age specific subgroup analysis showed the RBP might be higher in patient aged ≥18y than the control (SMD=0.82,95%CI:0.55~1.09,P<0.001), while difference between patient and control aged <18y were insignificant (SMD=1.68,95%CI:-0.22~3.59,P=0.08). Sensitivity and publication bias analyses indicated that our results were stable and without obvious publication bias.【Conclusion】 The meta-analysis shows that serum RBP might be higher in patients aged ≥18y with NAFLD than non-NAFLD patients.
郭宽鹏, 张林, 莫丽亚, 胡彬. 视黄醇结合蛋白水平与非酒精性脂肪肝相关性的Meta分析[J]. 医学临床研究, 2018, 35(10): 1873-1876.
GUO Kuan-peng, ZHANG Lin, MO Li-ya, et al. Association between Retinol Binding Protein and Non-alcoholic Fatty Liver Disease: a Meta-analysis. JOURNAL OF CLINICAL RESEARCH, 2018, 35(10): 1873-1876.
[1] 黄春明, 李瑜元. 非酒精性脂肪肝的流行病学[J].现代消化及介入诊疗, 2009, 4(14):233-237. [2] 康如彤, 钟燕, 蒋耀辉, 等. 肥胖儿童非酒精性脂肪肝影响因素分析[J].实用预防医学, 2013, 3(20):277-279. [3] Tonjes A, Bluher M, Stumvoll M. Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease[J].Curr Pharm Des,2010, 16(17):1921-1928. [4] Wu H, Jia W, Bao Y,et al. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[J].Diabetes Res Clin Pract,2008, 79(2):185-190. [5] 桑谊荃, 马向华, 倪娟, 等. 视黄醇结合蛋白4与新诊断2型糖尿病合并非酒精性脂肪肝的关系研究[J].南京医科大学学报(自然科学版), 2013, 5(33):646-650. [6] Seo JA, Kim NH, Park SY, et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease[J].Clin Endocrinol (Oxf),2008, 68(4):555-560. [7] Huang SC, Yang YJ. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level[J].J Pediatr Gastroenterol Nutr,2013, 56(2):145-150. [8] Boyraz M, Cekmez F, Karaoglu A, et al. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease[J].Biomark Med,2013, 7(5):737-745. [9] Cengiz C, Ardicoglu Y, Bulut S, et al. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis[J].Eur J Gastroenterol Hepatol,2010, 22(7):813-819. [10] Suh JB, Kim SM, Cho GJ, et al. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease[J].Scand J Gastroenterol,2014, 49(8):979-985. [11] Terra X, Auguet T, Broch M, et al. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women[J].Obesity (Silver Spring),2013, 21(1):170-177. [12] 丁海娟, 欧映伟, 刘春香. 视黄醇结合蛋白与非酒精性脂肪肝的相关性研究[J].医学综述, 2014, 5(20):936-938. [13] 刘琦, 曹燕, 宋阳, 等. RBP-4及网膜素与NAFLD患者胰岛素抵抗的关系研究[J].中国医药指南, 2015, 16:208. [14] 周晓倩, 张涛, 洪阳, 等. 血清视黄醇结合蛋白4与2型糖尿病并非酒精性脂肪肝患者相关性研究[J].贵州医药, 2014, 1:20-22. [15] 张书友, 孙剑, 余海鹰, 等. 精神分裂症患者血清视黄醇结合蛋白4与非酒精性脂肪肝的关系[J].中华行为医学与脑科学杂志, 2014, 12(23):1095-1098. [16] 张洪梅, 许华强, 张建武, 等. 非酒精性脂肪肝患者血清RBP4水平与胰岛素抵抗等相关性研究[J].中华全科医学, 2011, 2(09):211-212. [17] 许菊梅. 血清视黄醇结合蛋白4与非酒精性脂肪肝病的相关性研究[J].中国实用医药, 2010, 10(05):7-8. [18] Majerczyk M, Olszanecka-Glinianowicz M, Puzianowska-Kuznicka M, et al. Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance[J].Postepy Hig Med Dosw (Online),2016, 70:1267-1275. [19] Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity[J].Diabetes,2004, 53(Suppl 1):S43-S50. [20] Yan H, Chang X, Xia M, et al. Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study[J].Lipids Health Dis,2013, 12:157.
2018, Vol. 35 
